$RCKT news
The latest RCKT stock news: headlines, filings, AI summaries and sentiment for $RCKT, updated around the clock.
- Goldman Sachs Upgrades Rocket Pharmaceuticals Stock
- Rocket Pharmaceuticals Advances Phase 2 Trial for RP-A501 in Danon Disease
- ROCKET PHARMACEUTICALS, INC. - 8-K Filing
- Nearly Half of Homebuyers Receive Seller Concessions as Housing Market Shifts Toward Buyers
- Redfin Reports Pending Home Sales Dip to Lowest Level in Nearly Three Years
- Needham Upgrades Rocket Pharmaceuticals Stock Following Positive FDA Feedback
- San Antonio Becomes Top Migration Destination for Gen Z While Millennials Head to Houston
- ROCKET PHARMACEUTICALS, INC. - 8-K Filing
- U.S. Housing Market Reaches Strongest Buyer-Friendly Conditions on Record
- High Homebuying Costs Are Deterring Some Buyers and Shifting Market Power
- U.S. Housing Supply Reaches a Six-Year High in August
- San Francisco Housing Market Rises While Seattle Falls Amid Tech Sector Divergence
- ROCKET PHARMACEUTICALS, INC. - 8-K Filing
- ROCKET PHARMACEUTICALS, INC. - 8-K Filing
- Rocket Pharmaceuticals Reports Q1 2026 Net Loss of $47.6M
- ROCKET PHARMACEUTICALS, INC. - 8-K Filing
- ROCKET PHARMACEUTICALS, INC. - 10-Q Filing
- Cryoport Reports Q1 2026 Earnings with Revenue Growth and Expansion in Cell and Gene Therapy Services